Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArgentex Group. Regulatory News (AGFX)

  • This share is currently suspended. It was suspended at a price of 2.45
  • There is currently no data for AGFX

Trading Update

21 Jan 2025 07:00

RNS Number : 0148U
Argentex Group PLC
21 January 2025
 

 

21 January 2025

 

Argentex Group PLC

("Argentex" or the "Group")

Trading update

 

 

Full year revenues ahead of expectations; margins in line

Revenue diversification plans on track

 

 

Argentex Group PLC (AIM: AGFX), the global specialist in currency risk management and alternative banking, today announces a trading update for the 12-month period ended 31 December 2024.

Highlights

· Full year revenues* marginally higher than FY23 and ahead of market expectation

· Full year EBITDA margin* in line with expectation

· Australian and Dubai licences granted in year and regions now fully operational

· Argentex Global Platform build progressing to plan

· Leadership strengthened across the business

Trading Update

The Board expects to report FY24 revenues of approximately £50.3m*, marginally ahead of FY23 (£49.9m), and ahead of our mid £40 millions original expectations for the year. Whilst the adverse market conditions experienced during 2023 in the core FX business continued into the first quarter of 2024, trading momentum improved subsequently, with the business returning to year on year growth in the second half and revenues in H2 exceeding those generated in H1.

The Group continues to make good progress across its core areas of strategic focus, in particular diversifying its revenue streams through entering additional geographies and launching new products and services. Notwithstanding this continued investment into its strategic pillars the Board is confident that it will meet the original low single digit EBITDA margin expectation for the year.

 

Strong Momentum in Overseas Expansion

We were delighted to be granted licences to operate in both Australia and Dubai during the year, which was a key strategic priority and will significantly increase our addressable market. Both offices are now fully staffed and operational and should contribute to revenues this year.

In Australia, we were granted an Australian Financial Services Licence (AFSL) in May 2024. The licence, granted by the Australian Securities and Investments Commission (ASIC), allows Argentex's Australian entity (Argentex Pty Ltd) to offer bespoke currency risk management solutions and global accounts to wholesale clients across Australia.

In Dubai, we have announced the launch of Argentex (DIFC) Ltd, a fully licensed subsidiary regulated by the Dubai Financial Services Authority (DFSA). Led by our UAE Managing Director Jamil Khammu, we have a highly experienced team in place to serve sophisticated corporate and institutional clients across the DIFC and broader UAE market. Argentex (DIFC) Ltd is fully regulated under a Category 3A DFSA licence, enabling the team to offer comprehensive FX and payment services.

 

 

Product Diversification on Track

We continue to diversify into the broader payments and alternative banking markets, which will bring additional and more visible revenue streams; increase the Group's overall addressable market and improve customer retention.

To support this initiative, we made a number of key technology hires in the period to help re-platform the business onto one Argentex Global Platform ("AGP") and roll out a new suite of services. In particular, Tim Rudman has joined as Chief Operating Officer, alongside a number of other key hires. Tim and his team have developed a detailed product and technology roadmap with a key focus on automation, efficiency and improving the customer experience via a self-serve model. Progress to date has been excellent: milestones have been met ahead of schedule and we remain on track to launch new services in H2 2025. 

 

Jim Ormonde, CEO, said:

"We have made substantial strategic and operational progress in 2024 with a focus on revenue diversification through geographical expansion and the launch of new products and services, whilst making the business more efficient and resilient from an operational perspective. We have added significant expertise across the business including permanent appointments to our executive team and new experienced leadership within alternative banking, operations and technology. It has been a busy year and I am delighted with the progress made. We have invested for growth in 2024 and have made major changes to the business. With a strong team now in place, and a clear roadmap for the future, I am excited about the prospects for 2025 as multiple new profit generating revenue streams commence."

 

*FY24 results are yet to be subject to statutory audit.

 

For further information, please contact:

 

Argentex Group PLC

Jim Ormonde - Chief Executive Officer

Guy Rudolph - Chief Financial Officer

investorrelations@argentex.com

 

Teneo (Financial PR)

James Macey-White / Victoria Boxall / Rashida Salemahomed

argentex@teneo.com, 020 7260 2700

 

Singer Capital Markets (Nominated Adviser and Broker)

Tom Salvesen / James Maxwell / Asha Chotai

020 7496 3000

 

This announcement contains inside information for the purposes of the UK version of the Market Abuse Regulation ("MAR") which forms part of UK law by virtue of the European Union (Withdrawal) Act 2018; as amended. Upon publication of this announcement, the inside information is now considered to be in the public domain for the purposes of MAR.

 

About Argentex

Argentex (AIM: AGFX) is a global expert in currency risk management and alternative banking. Established in 2012 and headquartered in London, Argentex listed on London's AIM market in mid-2019 and has since added operations in Amsterdam, Dubai and Australia.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPKKBPABKDODB
Date   Source Headline
26th Oct 20237:00 amRNSBoard Change
13th Sep 20237:00 amRNSInterim results for the six months to 30 June 2023
19th Jul 20232:36 pmRNSTR1 Disclosure - Gresham House Asset Management
18th Jul 20237:00 amRNSNotice of Interim Results
12th Jul 202312:55 pmRNSDirector / PDMR Dealing
10th Jul 20237:00 amRNSHalf year trading update and board changes
27th Jun 202312:20 pmRNSTR1 Notification
22nd Jun 20239:46 amRNSResult of AGM
20th Apr 20235:05 pmRNSPublication of Annual Report and Notice of AGM
12th Apr 20237:00 amRNSFull results for the 9 months to 31 December 2022
30th Mar 20237:00 amRNSNotice of Results and Presentations
13th Mar 20237:00 amRNSUpdate on counterparties
28th Feb 20237:00 amRNSBoard Announcement
26th Jan 20237:00 amRNSTrading Statement
12th Dec 20227:00 amRNSTrading Statement
17th Nov 20222:08 pmRNSDirector/PDMR Shareholding
10th Nov 20227:00 amRNSGrant of Awards Under New LTIP
8th Nov 202212:55 pmRNSNew Long Term Incentive Plan
8th Nov 20227:00 amRNSInterim Results
12th Oct 20227:00 amRNSNotice of Interim Results
3rd Oct 20227:00 amRNSTrading Update
23rd Sep 20226:05 pmRNSHolding(s) in Company
16th Sep 20227:00 amRNSNetherlands Electronic Money Licence granted
9th Sep 20221:10 pmRNSHolding(s) in Company
22nd Aug 20221:59 pmRNSResult of AGM
15th Jul 20227:00 amRNSPublication of Annual Report and Notice of AGM
6th Jul 20227:00 amRNSFull year results for period ended 31 March 2022
31st May 20227:00 amRNSNotice of Results
12th Apr 20227:00 amRNSTrading Update
8th Nov 20217:00 amRNSInterim Results
1st Nov 20217:00 amRNSInterim Results Presentations
11th Oct 20217:00 amRNSTrading Statement
27th Aug 20215:21 pmRNSHolding(s) in Company
13th Aug 20212:16 pmRNSHolding(s) in Company
12th Aug 20214:09 pmRNSHolding(s) in Company
12th Aug 20213:09 pmRNSHolding(s) in Company
12th Aug 20213:08 pmRNSHolding(s) in Company
11th Aug 20211:08 pmRNSHolding(s) in Company
11th Aug 20219:41 amRNSDirector/PDMR Shareholding
4th Aug 20216:08 pmRNSResult of AGM
29th Jul 20217:00 amRNSChange to AGM Arrangements
13th Jul 202112:04 pmRNSHolding(s) in Company
12th Jul 20217:00 amRNSPublication of Annual Report and Notice of AGM
5th Jul 20212:22 pmRNSHolding(s) in Company
1st Jul 20217:00 amRNSFull year results for period ending 31 March 2021
22nd Jun 20217:00 amRNSNotice of Results
11th Jun 20217:00 amRNSDirectorate Change
10th May 20217:00 amRNSManagement team update
12th Apr 20218:00 amRNSExtension of audit partner's tenure & audit tender
6th Apr 20217:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.